Clinical Trials
12
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials
A Phase 3 Trial of MM120 for Major Depressive Disorder (Emerge)
- Conditions
- Major Depressive Disorder
- Interventions
- Other: PlaceboDrug: MM120 (LSD D-Tartrate)
- First Posted Date
- 2025-04-24
- Last Posted Date
- 2025-08-21
- Lead Sponsor
- Mind Medicine, Inc.
- Target Recruit Count
- 140
- Registration Number
- NCT06941844
- Locations
- 🇺🇸
Adams Clinical Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Preferred Research Partner, Fayetteville, Arkansas, United States
🇺🇸Preferred Research Partners, Inc, Little Rock, Arkansas, United States
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Other: PlaceboDrug: MM120 (LSD D-Tartrate)
- First Posted Date
- 2025-02-05
- Last Posted Date
- 2025-08-28
- Lead Sponsor
- Mind Medicine, Inc.
- Target Recruit Count
- 250
- Registration Number
- NCT06809595
- Locations
- 🇨🇿
Psyon s.r.o., Prague, Czechia
🇩🇪Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin Berlin, Berlin, Germany
🇺🇸Preferred Research Partners, Inc., Little Rock, Arkansas, United States
A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Voyage)
- Conditions
- Generalized Anxiety Disorder
- Interventions
- Other: PlaceboDrug: MM120 (LSD D-Tartrate)
- First Posted Date
- 2024-12-18
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Mind Medicine, Inc.
- Target Recruit Count
- 200
- Registration Number
- NCT06741228
- Locations
- 🇺🇸
Lighthouse Psychiatry, Gilbert, Arizona, United States
🇺🇸Kadima Neuropsychiatry Institute, La Jolla, California, United States
🇺🇸UCSF Department of Neurology, San Francisco, California, United States
A Dose-Finding Study of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms
- Conditions
- Anxiety Generalized
- Interventions
- Other: PlaceboDrug: MM-120 (LSD D-Tartrate)
- First Posted Date
- 2022-06-07
- Last Posted Date
- 2025-03-20
- Lead Sponsor
- Mind Medicine, Inc.
- Target Recruit Count
- 198
- Registration Number
- NCT05407064
- Locations
- 🇺🇸
Preferred Research Partners, Little Rock, Arkansas, United States
🇺🇸Irvine Center for Clinical Research, Irvine, California, United States
🇺🇸Kadima Neuropsychiatry Institute, La Jolla, California, United States
Safety and Efficacy of Low Dose MM-120 for ADHD Proof of Concept Trial
- First Posted Date
- 2022-01-21
- Last Posted Date
- 2025-04-13
- Lead Sponsor
- Mind Medicine, Inc.
- Target Recruit Count
- 53
- Registration Number
- NCT05200936
- Locations
- 🇳🇱
Maastricht University, Maastricht, Netherlands
🇨🇭University Hospital Basel, Basel, Switzerland
- Prev
- 1
- 2
- Next